SCHEMBL7373322

SCHEMBL7373322

COc1ccc(S(=O)(=O)NC(C(=O)NO)c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 7/20 0.57
MMP1 P03956 7/20 0.57
MMP13 P45452 6/20 0.57
BMP1 P13497 4/20 0.56
MMP2 P08253 6/20 0.55
MMP3 P08254 4/20 0.55
MMP7 P09237 2/20 0.55
PDE4A P27815 1/20 0.54
PDE4B Q07343 1/20 0.54
PDE4C Q08493 1/20 0.54
PDE4D Q08499 1/20 0.54
SLC1A3 P43003 1/20 0.52
SLC1A2 P43004 1/20 0.52
SLC1A1 P43005 1/20 0.52
MMP8 P22894 2/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
ADAM17 P78536 1/20 0.51
ADAMTS7 Q9UKP4 1/20 0.51
ADAMTS5 Q9UNA0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7373320 1.00 MMP9 (0.57) MMP9MMP1MMP13BMP1MMP2
SCHEMBL7383649 0.88 SLC1A3 (0.59) MMP9MMP1MMP13MMP2MMP3
Hydrochloric Acid SCHEMBL8513671 0.86 SLC1A3 (0.58) MMP9MMP1MMP13MMP2MMP3
SCHEMBL7380941 0.86 SLC1A3 (0.54) MMP9MMP1MMP13MMP2MMP3
SCHEMBL7024095 0.86 KDM4E (0.61) MMP9MMP1MMP13BMP1MMP2
SCHEMBL4538018 0.86 HDAC8 (0.60) MMP9MMP1MMP13MMP2MMP3
SCHEMBL3950460 0.81 ADAM17 (0.76) MMP9MMP1MMP13MMP2MMP7
SCHEMBL3940975 0.81 ADAM17 (0.76) MMP9MMP1MMP13MMP2MMP7
SCHEMBL7381660 0.81 MMP2 (0.75) MMP9MMP1MMP13BMP1MMP2
SCHEMBL7381656 0.81 MMP2 (0.75) MMP9MMP1MMP13BMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934267-B1 ALPHA-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS UPJOHN CO (US) 2002-01-30 EP claimed
EP-0934267-A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY (US) 1999-08-11 EP claimed
US-5804593-A FOR TREATMENT OF CONNECTIVE TISSUE DEGRADATION, OSTEO-, RHEUMATOID-, AND SEPTIC ARTHRITIS; OSTEOPENIAS, OSTEOPOROSIS, CORNEAL ULCERATION, PERIDONTAL DISEASE, GASTRIC ULCERS. PHARMACIA & UPJOHN COMPANY (US) 1998-09-08 US claimed
WO-1998017645-A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY (US) 1998-04-30 WO claimed
EP-0934267-B1 ALPHA-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS UPJOHN CO (US) 2002-01-30 EP disclosed
EP-0934267-A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY (US) 1999-08-11 EP disclosed
US-5804593-A FOR TREATMENT OF CONNECTIVE TISSUE DEGRADATION, OSTEO-, RHEUMATOID-, AND SEPTIC ARTHRITIS; OSTEOPENIAS, OSTEOPOROSIS, CORNEAL ULCERATION, PERIDONTAL DISEASE, GASTRIC ULCERS. PHARMACIA & UPJOHN COMPANY (US) 1998-09-08 US disclosed
WO-1998017645-A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA & UPJOHN COMPANY (US) 1998-04-30 WO disclosed